Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

ADVMADVM
8 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ADVERUM BIOTECHNOLOGIES INC

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of ADVM (ADVERUM BIOTECHNOLOGIES INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$2.7M

Total Shares Change

-193,516

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$4.60
0
2025-Q3
Unchanged
184,762
0.0%
$837,3160.0%$4.60
0
2025-Q2
Decreased
184,762
-59.1%
$397,3880.0%$2.32
0
2025-Q1
Increased
451,258
+2.0%
$2M0.0%$4.61
26
2024-Q4
Increased
442,490
+0.8%
$2.1M0.0%$4.69
26
2024-Q3
Decreased
439,056
-3.7%
$3.1M0.0%$6.94
0
2024-Q2
Increased
455,787
+135.5%
$3.1M0.0%$6.86
43
2024-Q1
New
193,516
-
$2.7M0.0%$14.14
36

Other major holders of ADVM: FRANKLIN TEMPLETON INC, FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used